Dr. Garo Armen, Chairman and CEO of Agenus Inc., examines adjuvants and their potential in light of the growing interest and favorable market scene for cancer vaccines... [
more ]
by Dr. Garo Armen, Agenus Inc.
From publishing our single newspaper in January 2005 to celebrating our eighth year in 2012, ddn continues to produce many vehicles that disseminate the news... [
more ]
A quick Google search for the phrase “outcomes-based medicine” yields results in the tens of thousands. When you look at a lot of these results, however, the focus is on scientific method and not, ironically, on outcomes—which is the point of medicine, isn’t it? .. [
more ]
by Randall C. Willis
The merged ALA and SBS groups, now known as
SLAS, launch first-ever joint annual meeting. Find out what's new at the show and what's notable. At the end of the list of stories is a link to another couple of stories about social events at the show and local attractions in San Diego. (
